Literature DB >> 33531038

The potential role of chemotaxis and the complement system in the formation and progression of thoracic aortic aneurysms inferred from the weighted gene coexpression network analysis.

Chuxiang Lei1, Dan Yang2, Wenlin Chen3, Haoxuan Kan1, Fang Xu1, Hui Zhang1, Wei Wang1, Lei Ji1, Yuehong Zheng4.   

Abstract

BACKGROUND: Thoracic aortic aneurysm (TAA) can be life-threatening due to the progressive weakening and dilatation of the aortic wall. Once the aortic wall has ruptured, no effective pharmaceutical therapies are available. However, studies on TAA at the gene expression level are limited. Our study aimed to identify the driver genes and critical pathways of TAA through gene coexpression networks.
METHODS: We analyzed the genetic data of TAA patients from a public database by weighted gene coexpression network analysis (WGCNA). Modules with clinical significance were identified, and the differentially expressed genes (DEGs) were intersected with the genes in these modules. Gene Ontology and pathway enrichment analyses were performed. Finally, hub genes that might be driving factors of TAA were identified. Furthermore, we evaluated the diagnostic accuracy of these genes and analyzed the composition of immune cells using the CIBERSORT algorithm.
RESULTS: We identified 256 DEGs and two modules with clinical significance. The immune response, including leukocyte adhesion, mononuclear cell proliferation and T cell activation, was identified by functional enrichment analysis. CX3CR1, C3, and C3AR1 were the top 3 hub genes in the module correlated with TAA, and the areas under the curve (AUCs) by receiver operating characteristic (ROC) analysis of all the hub genes exceeded 0.7. Finally, we found that the proportions of infiltrating immune cells in TAA and normal tissues were different, especially in terms of macrophages and natural killer (NK) cells.
CONCLUSION: Chemotaxis and the complement system were identified as crucial pathways in TAA, and macrophages with interactive immune cells may regulate this pathological process.

Entities:  

Keywords:  Chemotaxis; Immune infiltration; Thoracic aortic aneurysm; Weighted gene coexpression network analysis

Mesh:

Year:  2021        PMID: 33531038      PMCID: PMC7852290          DOI: 10.1186/s12967-021-02716-6

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


  48 in total

1.  LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections.

Authors:  Dong-Chuan Guo; Ellen S Regalado; Amelie Pinard; Jiyuan Chen; Kwanghyuk Lee; Christina Rigelsky; Lior Zilberberg; Ellen M Hostetler; Micheala Aldred; Stephanie E Wallace; Siddharth K Prakash; Suzanne M Leal; Michael J Bamshad; Deborah A Nickerson; Marvin Natowicz; Daniel B Rifkin; Dianna M Milewicz
Journal:  Am J Hum Genet       Date:  2018-04-05       Impact factor: 11.025

Review 2.  Complement and its role in innate and adaptive immune responses.

Authors:  Jason R Dunkelberger; Wen-Chao Song
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

Review 3.  Abdominal aortic aneurysm: update on pathogenesis and medical treatments.

Authors:  Jonathan Golledge
Journal:  Nat Rev Cardiol       Date:  2019-04       Impact factor: 32.419

4.  The Complement C3a-C3aR Axis Promotes Development of Thoracic Aortic Dissection via Regulation of MMP2 Expression.

Authors:  Weihong Ren; Yan Liu; Xuerui Wang; Chunmei Piao; Youcai Ma; Shulan Qiu; Lixin Jia; Boya Chen; Yuan Wang; Wenjian Jiang; Shuai Zheng; Chang Liu; Nan Dai; Feng Lan; Hongjia Zhang; Wen-Chao Song; Jie Du
Journal:  J Immunol       Date:  2018-01-24       Impact factor: 5.422

5.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

6.  Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.

Authors:  A Patel; V P Jagadesham; K E Porter; D J A Scott; S R Carding
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-03-04       Impact factor: 7.069

7.  Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms.

Authors:  William F Johnston; Morgan Salmon; Nicolas H Pope; Akshaya Meher; Gang Su; Matthew L Stone; Guanyi Lu; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

8.  Immunohistochemical analysis of the natural killer cell cytotoxicity pathway in human abdominal aortic aneurysms.

Authors:  Irene Hinterseher; Charles M Schworer; John H Lillvis; Elizabeth Stahl; Robert Erdman; Zoran Gatalica; Gerard Tromp; Helena Kuivaniemi
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

9.  cytoHubba: identifying hub objects and sub-networks from complex interactome.

Authors:  Chia-Hao Chin; Shu-Hwa Chen; Hsin-Hung Wu; Chin-Wen Ho; Ming-Tat Ko; Chung-Yen Lin
Journal:  BMC Syst Biol       Date:  2014-12-08

10.  Deciphering the stromal and hematopoietic cell network of the adventitia from non-aneurysmal and aneurysmal human aorta.

Authors:  Charles-Antoine Dutertre; Marc Clement; Marion Morvan; Knut Schäkel; Yves Castier; Jean-Marc Alsac; Jean-Baptiste Michel; Antonino Nicoletti
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.